Cromwell Holdings’s Viatris VTRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$56.5K Buy
3,561
+1,229
+53% +$19K 0.03% 469
2026
Q1
$31.5K Buy
2,332
+29
+1% +$406 0.02% 522
2025
Q4
$28.7K Sell
2,303
-1,243
-35% -$13.4K 0.02% 539
2025
Q3
$35.1K Buy
3,546
+2,786
+367% +$27.1K 0.02% 528
2025
Q2
$6.79K Sell
760
-2,277
-75% -$19.3K ﹤0.01% 612
2025
Q1
$26.5K Sell
3,037
-647
-18% -$6.79K 0.02% 547
2024
Q4
$45.9K Buy
3,684
+167
+5% +$2.05K 0.03% 478
2024
Q3
$40.8K Hold
3,517
0.03% 496
2024
Q2
$37.4K Buy
+3,517
New +$38.9K 0.02% 498

Other funds holding VTRS

Cromwell Holdings's VTRS Position: Q2 2026 in Review

Cromwell Holdings increased its Viatris (VTRS) stake by 53% in Q2 2026, buying an estimated $19K and bringing the position to 3,561 shares worth $56.5K. The position accounts for 0.03% of the portfolio, ranked #469.

Cromwell Holdings first reported a position in VTRS in Q2 2024 and has held it in 9 quarters since. 1,026 funds tracked by Wall St. Rank hold VTRS as of Q2 2026.

  • Cromwell Holdings held 3,561 shares of Viatris worth $56.5K as of Q2 2026.
  • Cromwell Holdings bought 1,229 Viatris shares in Q2 2026, an estimated $19K.
  • Viatris made up 0.03% of Cromwell Holdings's portfolio in Q2 2026, its #469 holding.
  • Cromwell Holdings first reported a position in Viatris in Q2 2024 and has held it in 9 quarters since.
  • 1,026 funds tracked by Wall St. Rank held Viatris as of Q2 2026.

Based on Cromwell Holdings's 13F filing for Q2 2026, filed 14 Jul 2026.